Vaccines Versus Variants
The latest pandemic narrative pits the newly discovered, highly infectious COVID-19 variants against the efforts to vaccinate as many people...
Prospect Theory in Healthcare
Healthcare is irrational and patients behave irrationally. Yet we continue to develop healthcare models assuming that patients are rational. Behavioral...
Echo Chambers in Healthcare
Our senses are our world. So what we perceive is what we believe. With the perceptions gleaned during a patient...
Familiarity Biases
History may not repeat itself, but it does rhyme. And the tendency to seek the familiar out of the new...
Obesity is Complicated
Obesity is a complex medical condition treated through both behavioral changes and medical intervention. But to truly help patients cope...
COVID-19’s Honor System
The vaccine roll-out has been predictably unpredictable, with chaos now the norm. With all the uncertainty around when many will...
J&J COVID-19 Go-To-Market Strategy
Market entry may be a sprint, but market dominance is a marathon. And those who end up winning the market...
Persistent Racial Biases
The fault is not in our stars, but in ourselves. In the subtle, implicit biases we continue to carry across...
Did The Pandemic Improve After Inauguration?
If perception is reality, then does the perception that the pandemic will improve under Biden create the reality that the...
Healthcare Is A (Positive) Right
The pandemic has shown that public health and individual rights have an uneasy relationship. But this does not have to...
Healthcare Trends
Financial traders will tell you that market trends are more powerful than any one trading strategy. Similarly in healthcare, we...
The Future of Healthcare Law
COVID-19 has changed much about healthcare. Its greatest change may come in how we structure and interpret healthcare law. We...
Videos
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more